Company Profile
Tonix Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- TNXP
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
11.71 USD (-6.58%)
Close
Last updated: July 13, 2026 at 00:00
199.74M USD
Market cap
Why the stock is moving
TNXP is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Tonix Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Tonix Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Tonix Pharmaceuticals follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Tonix Pharmaceuticals sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA®
Source: Tonix Pharmaceuticals
- 04
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Tonix Pharmaceuticals (TNXP)?
Tonix Pharmaceuticals (TNXP) most recently closed at 11.71 USD, a -6.58% move versus the previous session.
What is the market cap of Tonix Pharmaceuticals (TNXP)?
Tonix Pharmaceuticals currently has a market capitalization of 199.74M USD on BioPharmSignal.
What does Tonix Pharmaceuticals do?
Tonix Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is TNXP stock listed?
Tonix Pharmaceuticals (TNXP) is associated with NASDAQ, United States, Biotechnology.
What is Tonix?
Tonix Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Tonix Pharmaceuticals targeting with Tonix?
Tonix Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Pharmaceuticals?
Tonix Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.